Case Report: Concurrent transcatheter aortic and mitral valve replacement for symptomatic concomitant aortic and mitral valve stenoses
2024

Double Valve Replacement for Heart Disease

publication Evidence: low

Author Information

Author(s): Bussmann Benjamin Mothibe, Dawkins Sam, Newton James, Cahill Thomas

Primary Institution: Oxford University Hospitals NHS Trust

Hypothesis

Can concurrent transcatheter aortic and mitral valve replacement improve outcomes for patients with multi-valve disease?

Conclusion

The study demonstrates that concurrent transcatheter aortic and mitral valve replacement is feasible and can improve patient outcomes.

Supporting Evidence

  • Multi-valve disease is common in patients undergoing TAVI and is associated with worse outcomes.
  • Concurrent procedures can improve patient experience and reduce hospital admissions.
  • The heart valve team plays a crucial role in guiding treatment strategies.

Takeaway

Doctors can fix two heart valves at the same time using a special method, which helps patients feel better faster.

Methodology

The patient underwent concurrent transcatheter aortic valve implantation and transcatheter mitral valve replacement under general anesthesia with echocardiographic guidance.

Limitations

The study is based on a single case report, limiting generalizability.

Participant Demographics

A 76-year-old woman with severe aortic and mitral valve stenosis.

Digital Object Identifier (DOI)

10.3389/fcvm.2024.1487061

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication